Cathay Industrial Biotech (CBIO) Files $200M IPO

Cathay Industrial Biotech Ltd. (Nasdaq: CBIO) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of it's American Depositary Shares, or ADSs. The proposed maximum offering price is $200 million. Cathay filed to list on the New York Stock Exchange under the ticker "CBIO."

The offering is being made through Morgan Stanley, Deutsche Bank, and Jefferies.

Cathay Industrial is a global industrial biotechnology company as measured by production capacity in key biochemical products and a pioneer in the commercialization of bioprocess technologies

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Crescent Biopharma raises $143.7M in public offering on Nasdaq
• Array Technologies to acquire wire management firm for $203M
• BNY prices $500M preferred stock depositary share offering